These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3260954)

  • 21. Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians.
    Jacobsson LT; Turesson C; Hanson RL; Pillemer S; Sievers ML; Pettitt DJ; Bennett PH; Knowler WC
    Arthritis Rheum; 2001 May; 44(5):1170-6. PubMed ID: 11352251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgG subclasses of antibodies to type II collagen in rheumatoid arthritis differ from those in systemic lupus erythematosus and other connective tissue diseases.
    Cook AD; Mackay IR; Cicuttini FM; Rowley MJ
    J Rheumatol; 1997 Nov; 24(11):2090-6. PubMed ID: 9375865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of anti-SSA (Ro) antibodies in a Mexican population of patients with various systemic rheumatic diseases.
    García-de la Torre I; Sánchez-Guerrero A; Salmón-de la Torre G; Hernández-Vázquez L
    J Rheumatol; 1987 Jun; 14(3):479-81. PubMed ID: 3498034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A description of rheumatology practice. The American Rheumatism Association Committee on Rheumatologic Practice.
    Arthritis Rheum; 1977; 20(6):1278-81. PubMed ID: 143290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear matrix antibodies in rheumatic diseases.
    Kurki P; Virtanen I; Lehto VP; Helve T
    J Rheumatol; 1985 Apr; 12(2):253-6. PubMed ID: 3897532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased progression to rheumatoid arthritis or other connective tissue diseases in patients with palindromic rheumatism treated with antimalarials.
    Gonzalez-Lopez L; Gamez-Nava JI; Jhangri G; Russell AS; Suarez-Almazor ME
    J Rheumatol; 2000 Jan; 27(1):41-6. PubMed ID: 10648016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Undifferentiated systemic connective tissue disease-"overlap' in Zimbabwe.
    Lutalo SK; Glavintcheva I
    Cent Afr J Med; 1996 Jun; 42(6):166-9. PubMed ID: 8870313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Spontaneous secretion of antinuclear factors in systemic lupus erythematosus, rheumatoid arthritis and rheumatism].
    Benenson EV; Poverennyi AM; Podgorodnichenko VK; Sagandykova SKh
    Ter Arkh; 1985; 57(8):68-71. PubMed ID: 3878007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple specificities of autoantibodies against hnRNP A/B proteins in systemic rheumatic diseases and hnRNP L as an associated novel autoantigen.
    Siapka S; Patrinou-Georgoula M; Vlachoyiannopoulos PG; Guialis A
    Autoimmunity; 2007 May; 40(3):223-33. PubMed ID: 17453722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical utility of common serum rheumatologic tests.
    Lane SK; Gravel JW
    Am Fam Physician; 2002 Mar; 65(6):1073-80. PubMed ID: 11925083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
    Khan F; Siddiqui AA
    Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Importance of the determination of antibodies to n-DNA in systemic lupus erythematosus and other rheumatic diseases (comparative study of radioisotope and immunoenzyme technics)].
    Riazantseva TA; Shakhanina KL; Aroian AA; Speranskiĭ AI
    Ter Arkh; 1987; 59(8):86-91. PubMed ID: 3317973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bromocriptine in rheumatic and autoimmune diseases.
    McMurray RW
    Semin Arthritis Rheum; 2001 Aug; 31(1):21-32. PubMed ID: 11503136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advanced glycation endproducts (AGE) on IgG, a target for circulating antibodies in North American Indians with rheumatoid arthritis (RA).
    Newkirk MM; LePage K; Niwa T; Rubin L
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1129-38. PubMed ID: 9846895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Profiles of antibodies to histones, DNA and IgG in patients with systemic rheumatic diseases determined by ELISA.
    Gripenberg M; Helve T; Kurki P
    J Rheumatol; 1985 Oct; 12(5):934-9. PubMed ID: 3878880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A; Plischke H; Kellner H; Gruber R
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating autoantibodies to IgD in rheumatic diseases.
    Pope RM; Keightley R; McDuffy S
    J Immunol; 1982 Apr; 128(4):1860-3. PubMed ID: 6977573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extensive mitochondrial diversity within a single Amerindian tribe.
    Ward RH; Frazier BL; Dew-Jager K; Pääbo S
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8720-4. PubMed ID: 1681540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry).
    Ramos-Casals M; Muñoz S; Medina F; Jara LJ; Rosas J; Calvo-Alen J; Brito-Zerón P; Forns X; Sánchez-Tapias JM;
    J Rheumatol; 2009 Jul; 36(7):1442-8. PubMed ID: 19369460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased CD161+CD8+ T cells in the peripheral blood of patients suffering from rheumatic diseases.
    Mitsuo A; Morimoto S; Nakiri Y; Suzuki J; Kaneko H; Tokano Y; Tsuda H; Takasaki Y; Hashimoto H
    Rheumatology (Oxford); 2006 Dec; 45(12):1477-84. PubMed ID: 16638798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.